News : synergies

Moberg Derma AB and MedPharm Ltd today announce a license and distribution agreement for the development, marketing and sales of new dermatology products that will combine Moberg Derma’s Kaprolac® platform with MedPharm’s MedSpray™ technology. According to the agreement, MedPharm will be eligible for royalty payments.
Moberg Derma obtains the exclusive rights to worldwide manufacturing, distribution and sales...

Moberg Derma AB today announces the acquisition of two pharmaceutical projects in preclinical phase from Zelmic AB (Lund, Sweden). Zelmic will assist Moberg Derma in the future development of the projects. The two companies also agreed on a long term collaboration on future development projects. Financial terms were not disclosed.
“We have worked with the Zelmic team for some time and are impressed by their...